Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01099410 · ClinicalTrials.gov registry record
Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 17
- Enrollment target
NCT01099410: Completed study, sponsored by VA Office of Research and Development.
NCT01099410 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01099410 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the ability of two types of white blood cells to eat dead host cells, and how this process affects their ability to protect the body from infection. The two cell types are monocytes, a cell in the bloodstream, and alveolar macrophages, a cell in the lung that is ultimately derived from monocytes
Interventions
- PROCEDURE blood draw
- PROCEDURE Fiberoptic bronchoscopy
- PROCEDURE intravenous catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-02 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01099410
The ClinicalTrials.gov registry entry for NCT01099410 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which blood draw is the first listed.
NCT01099410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01099410 about?
NCT01099410 is a clinical study titled "Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)". The purpose of this study is to compare the ability of two types of white blood cells to eat dead host cells, and how this process affects their ability to protect the body from infection. The two cell types are monocytes, a cell in the bloodstream, and alveolar macrophages, a cell in the lung that ...
What is the current status of trial NCT01099410?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2010-02. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01099410?
The interventions under investigation include: blood draw (PROCEDURE), Fiberoptic bronchoscopy (PROCEDURE), intravenous catheter (PROCEDURE).
Who is sponsoring clinical trial NCT01099410?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.